Boost vitality, strength, and natural regeneration
The CJC/Ipamorelin protocol is one of the most advanced and well-tolerated peptide therapies for stimulating the natural release of growth hormone (GH). Combining CJC-1295, a GHRH analog, with Ipamorelin, a GHRP peptide, amplifies your body’s natural ability to restore muscle tone, improve recovery, and enhance energy — without synthetic hormones.
Schedule a ConversationCJC-1295and Ipamorelin are synergistic peptides designed to enhance the natural release of growth hormone from the pituitary gland.
Together, they promote a stronger, longer, and more balanced GH pulse — leading to improved regeneration, recovery, and vitality.
CJC-1295 prolongs GH secretion, while Ipamorelin initiates the release through complementary receptors.
The combination mimics the body’s GH cycles, maintaining hormonal balance.
Higher GH levels support muscle growth, metabolism, tissue repair, and collagen production.
This combination provides the benefits of growth hormone therapy without the risks associated with synthetic HGH.
Results typically become noticeable within a few weeks, with progressive improvements over 2–6 months.
This therapy is ideal for men and women who want to
Not recommended for
At Nuceria Wellness, every patient begins with a comprehensive hormonal and metabolic evaluation to confirm candidacy and create a personalized plan.
Subcutaneous injection (abdomen, thigh, or upper arm)
Once daily, typically at night
Refrigerate between 2–8 °C (36–46 °F); do not freeze
Often prescribed in cycles of 3–6 months for optimal results
Each dose and schedule is customized based on lab values, age, and desired outcomes.
Improved sleep, energy, and recovery
Noticeable muscle tone and fat reduction
Enhanced strength, endurance, and skin elasticity
CJC/Ipamorelin is well-tolerated and safe under medical supervision.
Common mild effects
Less common effects
All protocols at Nuceria are carefully monitored to ensure results and safety.
Optimize your performance, recovery, and longevity with the CJC/Ipamorelin peptide protocol. MyNuceria – Miami, FL